Fig. 3From: IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosisIC100 treatment does not affect splenic immune cell populations following EAE. Flow cytometric quantification of the leukocyte populations in the spleen at 35 dpi EAE. Results are expressed as average ± SEM of 5 mice/groupBack to article page